Previous studies have demonstrated that immunogenic peptides or tumour cell lysates conjugated to VLP are cross-presented to CD8+ T cells by DC more effectively than peptide or lysates delivered alone; however, the reasons underpinning this effect are not well defined (Win et al, 2011). Here, CD8A is linked to neoplasm.